Indefinite Delivery Contract 75N94020D00016
- Not listed
- The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to the University of Utah Office of Sponsored Projects Division to conduct clinical trials in support of contraceptive development. The multiple award IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, the prime contractor will receive task orders to finalize protocols, obtain regulatory approvals, and commence...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to The Regents of the University of California, San Francisco to conduct clinical trials in support of contraceptive development. With a potential value of $5 million and a period of performance through July 2027, this multiple-award contract enables the agency to issue task orders for phase I-IV contraceptive trials in women and treatment trials for gynecologic...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded Emory University multiple contracts to support its Contraceptive Development Program. Under an indefinite delivery contract with a potential value of $5 million, Emory will conduct clinical trials of contraceptive products and treatments for gynecologic conditions from 2020-2027 on a task order basis. Two task orders were issued, the first for $94,652 to finalize the protocol and commence patient...
- The National Institute of Child Health and Human Development (NICHD), part of the U.S. Department of Health and Human Services, awarded a $5,000,000 Indefinite Delivery Contract (IDC) to The Regents of the University of Colorado to conduct clinical trials for new contraceptive methods and treatments for gynecological conditions over a 7-year period ending in 2027. This IDC is part of NICHD's Contraceptive Development Program and Contraceptive Clinical Trials Network (CCTN), which aims to advance...
- The National Institutes of Health National Institute of Child Health and Human Development awarded an indefinite delivery contract to Essential Access Health to conduct clinical trials and develop protocols in support of the Contraceptive Development Program. The IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, Essential Access Health has received two cost-no-fee delivery orders to date. The first, valued at $349,327, tasks the contractor to...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded an indefinite delivery contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract has a potential value of $5,000,000 and period of performance through July 2027. Task orders issued to date include $92,034 for finalizing a clinical trial protocol and $103,767 to assist in developing new contraceptive products...
- The National Institutes of Health National Institute of Child Health and Human Development awarded an indefinite delivery contract to Boston Medical Center Corporation to conduct clinical trials of contraceptive products and treatments for gynecologic conditions. The IDV has a potential value of $5 million and a period of performance through July 2027. Under the IDV, Boston Medical Center has received multiple task orders to advance specific products and services. A $126,095 order finalized...
- The National Institutes of Health National Institute of Child Health and Human Development awarded a multiple award indefinite delivery contract to The Johns Hopkins University to conduct clinical research in support of contraceptive development and trials. With a potential value of $5,000,000 over a period from August 2020 through July 2027, the IDV enables task orders for protocol review, development assistance, and activities associated with the Contraceptive Clinical Trials Network...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded a multiple award indefinite delivery contract to the University of Hawaii at Manoa to support the agency's Contraceptive Development Program and Contraceptive Clinical Trials Network. The contract has a potential value of $5 million and period of performance through July 2027. Two delivery orders have been awarded against the contract to date. The first is a $64k order for protocol finalization...
- The National Institutes of Health National Institute of Child Health and Human Development awarded a multiple award IDV to various contractors to conduct clinical trials in support of contraceptive development and the Contraceptive Clinical Trials Network for female sites. Task orders were issued to the University of California, Davis for protocol finalization and start-up of the Ovaprene vaginal device clinical trial, as well as to provide assistance with protocol review and development...
- 75N94020D00016Indefinite Delivery Contract
- 4Federal Contract Awards
The National Institutes of Health's National Institute of Child Health and Human Development awarded Oregon Health & Science University an indefinite delivery contract with a potential value of $5,000,000 to conduct clinical trials in support of contraceptive development. Task orders issued against this contract include protocols for Phase 1 evaluation of the Ovaprene device ($181k), central laboratory services for pharmacokinetic analysis of levonorgestrel butanoate ($349k), and assistance with protocol review and development activities ($91k). Work performed under the contract advances the National Institute of Child Health and Human Development's Contraceptive Development Program goals by supporting the Contraceptive Clinical Trials Network through clinical evaluation of reproductive health technologies. Task orders issued to Oregon Health & Science University involve finalizing trial protocols, obtaining regulatory approvals, and initiating recruitment activities in Portland, Oregon for early-stage contraceptive device and drug evaluation studies. The indefinite delivery contract was awarded on August 1, 2020 and has a period of performance through July 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 7/22/22 | |
| P00002 | Other Administrative Action | $0 | 11/16/21 | |
| P00001 | Other Administrative Action | $0 | 7/30/21 | |
| Not listed | Not listed | $0 | 8/1/20 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 75N94020D00016-75N94025F00002 | Oregon Health & Science University | $723.6k | 8/1/25 | 1/31/26 | 7/24/25 | |
Delivery Order 75N94020D00016-75N94020F00001 | Oregon Health & Science University | $70.0k | 8/1/20 | 7/31/26 | 7/31/25 | |
Delivery Order 75N94020D00016-75N94021F00001 | Oregon Health & Science University | $444.8k | 2/9/21 | 2/8/26 | 8/22/24 | |
Delivery Order 75N94020D00016-75N94023F00001 | Oregon Health & Science University | $251.5k | 9/28/23 | 5/31/25 | 4/30/25 |